We are live on ! Find out more
KM

Kalos Management Portfolio holdings

AUM $46.6M
1-Year Est. Return 11.52%
This Fund
S&P 500
This Quarter Est. Return
-12.5%
1 Year Est. Return
+11.52%
3 Year Est. Return
+48.48%
5 Year Est. Return
+71.6%
10 Year Est. Return
AUM
$205M
AUM Growth
+$18.9M
Cap. Flow
+$32.4M
Cap. Flow %
15.77%
Top 10 Hldgs %
26.07%
Holding
203
New
40
Increased
84
Reduced
63
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 11.27%
2 Healthcare 10.02%
3 Financials 7.14%
4 Consumer Discretionary 5.06%
5 Real Estate 4.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MA icon
151
Mastercard
MA
$502B
$251K 0.12%
1,222
+186
+18% +$36.9K
HYG icon
152
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$249K 0.12%
3,066
-274
-8% -$22.9K
VTI icon
153
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$245K 0.12%
+1,732
New +$239K
QCOM icon
154
Qualcomm
QCOM
$155B
$239K 0.12%
4,254
-50
-1% -$3.04K
ARCC icon
155
Ares Capital
ARCC
$13.5B
$236K 0.11%
+14,657
New +$242K
VTV icon
156
Vanguard Morningstar Value ETF
VTV
$188B
$231K 0.11%
2,285
+450
+25% +$47.3K
UNFI icon
157
United Natural Foods
UNFI
$3.08B
$229K 0.11%
21,664
+1,427
+7% +$30K
IJH icon
158
iShares Core S&P Mid-Cap ETF
IJH
$122B
$221K 0.11%
6,000
+85
+1% +$3.1K
XLG icon
159
Invesco S&P 500 Top 50 ETF
XLG
$10.6B
$221K 0.11%
+10,140
New +$197K
CVX icon
160
Chevron
CVX
$392B
$218K 0.11%
1,847
+49
+3% +$5.68K
VUG icon
161
Vanguard Morningstar Growth ETF
VUG
$220B
$212K 0.1%
9,108
+1,068
+13% +$25.9K
GLD icon
162
SPDR Gold Trust
GLD
$131B
$211K 0.1%
+1,719
New +$200K
META icon
163
Meta Platforms (Facebook)
META
$1.42T
$209K 0.1%
1,409
-180
-11% -$26.1K
HTGM
164
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$179K 0.09%
413
+25
+6% +$15.5K
MAV
165
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
$177K 0.09%
17,266
+866
+5% +$9.04K
DBC icon
166
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
$171K 0.08%
11,255
+109
+1% +$1.79K
VKQ icon
167
Invesco Municipal Trust
VKQ
$541M
$168K 0.08%
15,100
+350
+2% +$3.89K
PHK
168
PIMCO High Income Fund
PHK
$867M
$167K 0.08%
20,882
+4,081
+24% +$33.2K
PRTK
169
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$160K 0.08%
24,450
+11,000
+82% +$83.5K
UDF
170
DELISTED
UNITED DEV FDG IV COM SHS OF BENE INT (TX)
UDF
$160K 0.08%
37,206
+22,964
+161% +$98.8K
GYRE icon
171
Gyre Therapeutics
GYRE
$641M
$147K 0.07%
2,441
+133
+6% +$9.81K
GE icon
172
GE Aerospace
GE
$374B
$139K 0.07%
3,267
+4
+0.1% +$181
CTSO icon
173
Cytosorbents Corp
CTSO
$22.7M
$120K 0.06%
14,700
DBRG icon
174
DigitalBridge
DBRG
$2.93B
$118K 0.06%
+4,706
New +$108K
FOLD
175
DELISTED
Amicus Therapeutics
FOLD
$117K 0.06%
10,750

Similar funds

Kalos Management's Q4 2018 Portfolio in Review

As of Q4 2018, Kalos Management held 203 positions worth $205M, up 10% from $186M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Kalos Management deployed $32.4M of net new capital in Q4 2018, opening 40 new positions and adding to 84 existing holdings. Its largest new stake was Schwab US Large- Cap ETF: 493,812 shares worth $5.99M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares S&P Small-Cap 600 Growth ETF, an estimated $5.91M trimmed.

  • Kalos Management's largest Q4 2018 buy was Schwab US Large- Cap ETF: 493,812 shares worth $5.99M.
  • Kalos Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $4.97M increase.
  • Kalos Management's biggest Q4 2018 reduction was iShares S&P Small-Cap 600 Growth ETF, cutting an estimated $5.91M.
  • Kalos Management fully exited iShares S&P Small-Cap 600 Value ETF in Q4 2018, selling an estimated $6.5M.
  • Kalos Management's ten largest holdings make up 26% of its $205M portfolio in Q4 2018.
  • Kalos Management opened 40 new positions and closed 9 in Q4 2018.
  • Kalos Management's portfolio value rose 10% quarter-over-quarter to $205M.

Based on Kalos Management's 13F filing for Q4 2018, filed 13 Feb 2019.